HEADER OXIDOREDUCTASE 26-SEP-04 1XK2 TITLE NADPH- AND ASCORBATE-SUPPORTED HEME OXYGENASE REACTIONS ARE DISTINCT. TITLE 2 REGIOSPECIFICITY OF HEME CLEAVAGE BY THE R183E MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEME OXYGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HO-1; COMPND 5 EC: 1.14.99.3; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HMOX1, HO1, HO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HEME, HEME DEGRADATION, CATALYTIC MECHANISM, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.WANG,L.LAD,T.L.POULOS,P.R.ORTIZ DE MONTELLANO REVDAT 4 20-OCT-21 1XK2 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1XK2 1 VERSN REVDAT 2 15-MAR-05 1XK2 1 JRNL REVDAT 1 09-NOV-04 1XK2 0 JRNL AUTH J.WANG,L.LAD,T.L.POULOS,P.R.ORTIZ DE MONTELLANO JRNL TITL REGIOSPECIFICITY DETERMINANTS OF HUMAN HEME OXYGENASE: JRNL TITL 2 DIFFERENTIAL NADPH- AND ASCORBATE-DEPENDENT HEME CLEAVAGE BY JRNL TITL 3 THE R183E MUTANT. JRNL REF J.BIOL.CHEM. V. 280 2797 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15525643 JRNL DOI 10.1074/JBC.M411229200 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 24132 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3486 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 206 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1XK2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-SEP-04. REMARK 100 THE DEPOSITION ID IS D_1000030444. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.53 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25306 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NH4SO4, HEPES, HEXANEDIOL, PH 7.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.35600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ARG A 3 REMARK 465 PRO A 4 REMARK 465 GLN A 5 REMARK 465 PRO A 6 REMARK 465 ASP A 7 REMARK 465 SER A 8 REMARK 465 MET A 9 REMARK 465 ASP A 224 REMARK 465 THR A 225 REMARK 465 LYS A 226 REMARK 465 ASP A 227 REMARK 465 GLN A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 SER A 231 REMARK 465 ARG A 232 REMARK 465 ALA A 233 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ARG B 3 REMARK 465 PRO B 4 REMARK 465 GLN B 5 REMARK 465 PRO B 6 REMARK 465 ASP B 7 REMARK 465 SER B 8 REMARK 465 MET B 9 REMARK 465 ASP B 224 REMARK 465 THR B 225 REMARK 465 LYS B 226 REMARK 465 ASP B 227 REMARK 465 GLN B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 SER B 231 REMARK 465 ARG B 232 REMARK 465 ALA B 233 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU B 23 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 39 31.96 -77.45 REMARK 500 PHE A 74 -35.96 -133.82 REMARK 500 GLU A 125 54.13 -147.80 REMARK 500 ARG A 136 -72.35 -76.58 REMARK 500 ASP A 156 50.86 38.05 REMARK 500 PRO A 158 -146.10 -60.38 REMARK 500 SER A 159 53.02 -141.00 REMARK 500 PRO B 72 -8.90 -59.92 REMARK 500 PHE B 74 -41.30 -132.25 REMARK 500 ARG B 136 -72.16 -64.41 REMARK 500 THR B 222 -78.12 -101.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 300 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 25 NE2 REMARK 620 2 HEM A 300 NA 99.6 REMARK 620 3 HEM A 300 NB 99.1 90.4 REMARK 620 4 HEM A 300 NC 95.6 164.7 88.5 REMARK 620 5 HEM A 300 ND 85.2 90.6 175.4 89.3 REMARK 620 6 HOH A 417 O 162.5 96.7 87.2 68.1 88.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 300 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 25 NE2 REMARK 620 2 HEM B 300 NA 89.0 REMARK 620 3 HEM B 300 NB 102.3 89.9 REMARK 620 4 HEM B 300 NC 95.1 175.9 89.4 REMARK 620 5 HEM B 300 ND 85.8 89.5 171.8 90.7 REMARK 620 6 HOH B 388 O 172.0 94.9 84.6 81.0 87.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XK3 RELATED DB: PDB DBREF 1XK2 A 1 233 UNP P09601 HMOX1_HUMAN 1 233 DBREF 1XK2 B 1 233 UNP P09601 HMOX1_HUMAN 1 233 SEQADV 1XK2 GLU A 183 UNP P09601 ARG 183 ENGINEERED MUTATION SEQADV 1XK2 GLU B 183 UNP P09601 ARG 183 ENGINEERED MUTATION SEQRES 1 A 233 MET GLU ARG PRO GLN PRO ASP SER MET PRO GLN ASP LEU SEQRES 2 A 233 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS THR SEQRES 3 A 233 GLN ALA GLU ASN ALA GLU PHE MET ARG ASN PHE GLN LYS SEQRES 4 A 233 GLY GLN VAL THR ARG ASP GLY PHE LYS LEU VAL MET ALA SEQRES 5 A 233 SER LEU TYR HIS ILE TYR VAL ALA LEU GLU GLU GLU ILE SEQRES 6 A 233 GLU ARG ASN LYS GLU SER PRO VAL PHE ALA PRO VAL TYR SEQRES 7 A 233 PHE PRO GLU GLU LEU HIS ARG LYS ALA ALA LEU GLU GLN SEQRES 8 A 233 ASP LEU ALA PHE TRP TYR GLY PRO ARG TRP GLN GLU VAL SEQRES 9 A 233 ILE PRO TYR THR PRO ALA MET GLN ARG TYR VAL LYS ARG SEQRES 10 A 233 LEU HIS GLU VAL GLY ARG THR GLU PRO GLU LEU LEU VAL SEQRES 11 A 233 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 A 233 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ASP SEQRES 13 A 233 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE SEQRES 14 A 233 PRO ASN ILE ALA SER ALA THR LYS PHE LYS GLN LEU TYR SEQRES 15 A 233 GLU SER ARG MET ASN SER LEU GLU MET THR PRO ALA VAL SEQRES 16 A 233 ARG GLN ARG VAL ILE GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 A 233 LEU ASN ILE GLN LEU PHE GLU GLU LEU GLN GLU LEU LEU SEQRES 18 A 233 THR HIS ASP THR LYS ASP GLN SER PRO SER ARG ALA SEQRES 1 B 233 MET GLU ARG PRO GLN PRO ASP SER MET PRO GLN ASP LEU SEQRES 2 B 233 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS THR SEQRES 3 B 233 GLN ALA GLU ASN ALA GLU PHE MET ARG ASN PHE GLN LYS SEQRES 4 B 233 GLY GLN VAL THR ARG ASP GLY PHE LYS LEU VAL MET ALA SEQRES 5 B 233 SER LEU TYR HIS ILE TYR VAL ALA LEU GLU GLU GLU ILE SEQRES 6 B 233 GLU ARG ASN LYS GLU SER PRO VAL PHE ALA PRO VAL TYR SEQRES 7 B 233 PHE PRO GLU GLU LEU HIS ARG LYS ALA ALA LEU GLU GLN SEQRES 8 B 233 ASP LEU ALA PHE TRP TYR GLY PRO ARG TRP GLN GLU VAL SEQRES 9 B 233 ILE PRO TYR THR PRO ALA MET GLN ARG TYR VAL LYS ARG SEQRES 10 B 233 LEU HIS GLU VAL GLY ARG THR GLU PRO GLU LEU LEU VAL SEQRES 11 B 233 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 B 233 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ASP SEQRES 13 B 233 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE SEQRES 14 B 233 PRO ASN ILE ALA SER ALA THR LYS PHE LYS GLN LEU TYR SEQRES 15 B 233 GLU SER ARG MET ASN SER LEU GLU MET THR PRO ALA VAL SEQRES 16 B 233 ARG GLN ARG VAL ILE GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 B 233 LEU ASN ILE GLN LEU PHE GLU GLU LEU GLN GLU LEU LEU SEQRES 18 B 233 THR HIS ASP THR LYS ASP GLN SER PRO SER ARG ALA HET HEM A 300 43 HET HEM B 300 43 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 5 HOH *206(H2 O) HELIX 1 1 ASP A 12 THR A 21 1 10 HELIX 2 2 THR A 21 ALA A 31 1 11 HELIX 3 3 ALA A 31 LYS A 39 1 9 HELIX 4 4 THR A 43 ASN A 68 1 26 HELIX 5 5 PHE A 74 TYR A 78 5 5 HELIX 6 6 PHE A 79 HIS A 84 1 6 HELIX 7 7 ARG A 85 GLY A 98 1 14 HELIX 8 8 ARG A 100 ILE A 105 1 6 HELIX 9 9 THR A 108 GLU A 125 1 18 HELIX 10 10 LEU A 128 GLY A 143 1 16 HELIX 11 11 GLY A 143 ASP A 156 1 14 HELIX 12 12 LEU A 164 THR A 168 5 5 HELIX 13 13 SER A 174 SER A 188 1 15 HELIX 14 14 THR A 192 LEU A 221 1 30 HELIX 15 15 ASP B 12 THR B 21 1 10 HELIX 16 16 THR B 21 ALA B 31 1 11 HELIX 17 17 ALA B 31 LYS B 39 1 9 HELIX 18 18 THR B 43 ASN B 68 1 26 HELIX 19 19 PHE B 74 TYR B 78 5 5 HELIX 20 20 PHE B 79 HIS B 84 1 6 HELIX 21 21 ARG B 85 GLY B 98 1 14 HELIX 22 22 ARG B 100 ILE B 105 1 6 HELIX 23 23 THR B 108 GLU B 125 1 18 HELIX 24 24 LEU B 128 ASP B 156 1 29 HELIX 25 25 LEU B 164 THR B 168 5 5 HELIX 26 26 SER B 174 SER B 188 1 15 HELIX 27 27 THR B 192 HIS B 223 1 32 LINK NE2 HIS A 25 FE HEM A 300 1555 1555 2.09 LINK FE HEM A 300 O HOH A 417 1555 1555 1.95 LINK NE2 HIS B 25 FE HEM B 300 1555 1555 2.13 LINK FE HEM B 300 O HOH B 388 1555 1555 2.07 SITE 1 AC1 17 LYS A 18 HIS A 25 ALA A 28 GLU A 29 SITE 2 AC1 17 MET A 34 GLN A 38 TYR A 134 THR A 135 SITE 3 AC1 17 ARG A 136 GLY A 139 SER A 142 GLY A 143 SITE 4 AC1 17 PHE A 207 ASN A 210 PHE A 214 HOH A 306 SITE 5 AC1 17 HOH A 417 SITE 1 AC2 14 LYS B 18 HIS B 25 MET B 34 GLN B 38 SITE 2 AC2 14 TYR B 134 THR B 135 ARG B 136 GLY B 139 SITE 3 AC2 14 SER B 142 PHE B 207 ASN B 210 PHE B 214 SITE 4 AC2 14 HOH B 372 HOH B 388 CRYST1 61.371 54.712 71.889 90.00 99.13 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016294 0.000000 0.002619 0.00000 SCALE2 0.000000 0.018278 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014089 0.00000 MASTER 326 0 2 27 0 0 9 6 0 0 0 36 END